Specially views on Likely impact of US FDA approval of karTX developed by Neuland labs for BRISTOL MYERS SQIB. Since Bristol Myer is planning to supply by October end to patients and Neuland likely to start production of karTX immediately.
| Subscribe To Our Free Newsletter |
